Enzolve Technologies has received substantial investment from Enterprise Ireland under the National Development Plan (2007-2013) and private investors. This investment will enable it to commence production of "NeoScreenPak", a range of diagnostic kits for screening a variety of disorders that effect newborn infants...

Read full article on the web     Innovations Report April 30, 2008      or in pdf format   

  Back to the News page